Clopidogrel Completed Phase 4 Trials for Coronary Heart Disease (CHD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01431495Clinical Assessment of Pidogrel® Versus Plavix® (CAPP)
NCT0014046575 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)
NCT00947843Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents